Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib Extended-Release Tablets in Refractory Uveitis
NCT07773623Phase 4Active, not recruiting
- Sponsor
- Tianjin Medical University
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 4 trial of upadacitinib in uveitis, sponsored by Tianjin Medical University. Started Jan 2025; status: active, not recruiting.
02
Drugs
upadacitinib
03
Conditions
uveitis
Beyond the preview
Go deeper on NCT07773623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07773623.